ADUS vs. AHCO, BTSG, EHAB, AVAH, AMED, OPCH, DVAX, USPH, PTGX, and ZLAB
Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include AdaptHealth (AHCO), BrightSpring Health Services (BTSG), Enhabit (EHAB), Aveanna Healthcare (AVAH), Amedisys (AMED), Option Care Health (OPCH), Dynavax Technologies (DVAX), U.S. Physical Therapy (USPH), Protagonist Therapeutics (PTGX), and Zai Lab (ZLAB). These companies are all part of the "medical" sector.
AdaptHealth (NASDAQ:AHCO) and Addus HomeCare (NASDAQ:ADUS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, community ranking, institutional ownership, media sentiment, dividends, valuation and profitability.
AdaptHealth has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.
Addus HomeCare has a net margin of 5.91% compared to Addus HomeCare's net margin of -21.21%. AdaptHealth's return on equity of 9.70% beat Addus HomeCare's return on equity.
Addus HomeCare has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.
Addus HomeCare received 218 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.82% of users gave Addus HomeCare an outperform vote while only 58.91% of users gave AdaptHealth an outperform vote.
AdaptHealth presently has a consensus target price of $12.10, suggesting a potential upside of 21.49%. Addus HomeCare has a consensus target price of $103.00, suggesting a potential upside of 8.95%. Given Addus HomeCare's higher probable upside, equities analysts plainly believe AdaptHealth is more favorable than Addus HomeCare.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 13.6% of AdaptHealth shares are owned by company insiders. Comparatively, 4.4% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Addus HomeCare had 5 more articles in the media than AdaptHealth. MarketBeat recorded 10 mentions for Addus HomeCare and 5 mentions for AdaptHealth. Addus HomeCare's average media sentiment score of 0.81 beat AdaptHealth's score of 0.48 indicating that AdaptHealth is being referred to more favorably in the media.
Summary
Addus HomeCare beats AdaptHealth on 13 of the 18 factors compared between the two stocks.
Get Addus HomeCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Addus HomeCare Competitors List
Related Companies and Tools
